Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Debt / NOTE 7.500% 5/0
-
Number of holders
-
7
-
Total 13F principal, excl. options
-
30,844,000
-
Principal change
-
+30,844,000
-
Total reported value, excl. options
-
$53,542,000
-
Value change
-
+$53,542,000
-
Number of buys
-
7
-
Price
-
$1.74
Significant Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 7.500% 5/0 as of Q4 2014
7 filings reported holding 868459AB4 - SUPERNUS PHARMACEUTICALS INC - NOTE 7.500% 5/0 as of Q4 2014.
SUPERNUS PHARMACEUTICALS INC - NOTE 7.500% 5/0 has 7 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $30,844,000 of principal
.
Largest 7 bondholders include Orchard Hill Capital Management LP ($10,708,000 of principal), ZAZOVE ASSOCIATES LLC ($9,599,000 of principal), 683 Capital Management, LLC ($8,100,000 of principal), Tekla Capital Management LLC ($2,000,000 of principal), Ameriprise Financial Inc ($217,000 of principal), WELLINGTON MANAGEMENT GROUP LLP ($170,000 of principal), and GOLDMAN SACHS GROUP INC ($50,000 of principal).
This table shows the top 7 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.